XML 55 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill and Intangible Assets, Net (Tables)
 12 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of changes in the carrying amount of goodwill
Changes in the carrying amount of goodwill were as follows:
(In millions)U.S. PharmaceuticalPrescription Technology SolutionsMedical-Surgical SolutionsInternationalTotal
Balance, March 31, 2021$3,963 $1,542 $2,453 $1,535 $9,493 
Goodwill acquired— — — 5 5 
Foreign currency translation adjustments, net(40)— — (7)(47)
Balance, March 31, 20223,923 1,542 2,453 1,533 9,451 
Goodwill acquired160 463 — 5 628 
Foreign currency translation adjustments, net(21)— — (99)(120)
Other adjustments(12)— — — (12)
Balance, March 31, 2023$4,050 $2,005 $2,453 $1,439 $9,947 
Schedule of information regarding intangible assets
Information regarding intangible assets were as follows:
March 31, 2023March 31, 2022
(Dollars in millions)Weighted-
Average
Remaining
Amortization
Period
(Years)		Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount		Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount
Customer relationships12$2,971 $(1,765)$1,206 $2,777 $(1,691)$1,086 
Service agreements101,137 (623)514 1,085 (573)512
Trademarks and trade names12833 (430)403 819(386)433
Technology11264 (129)135 128(116)12
Other10193 (174)19 187(171)16
Total
$5,398 $(3,121)$2,277 $4,996 $(2,937)$2,059 
(1)
(1)Excludes net intangible assets of approximately $384 million related to the European divestiture activities discussed in more detail in Financial Note 2, “Business Acquisitions and Divestitures.” This amount was included under the caption “Assets held for sale” in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale in the second and third quarters of fiscal 2022.